Principal Investigator
Fernanda Bellodi Schmidt
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20220006
Clinical Trial Summary
Double Blind, randomized, Phase II clinical study to evaluate safety and efficacy of ALLO-ASC-SHEET (allogenic human adipose tissue-derived mesenchymal stem cell sheet) versus vehicle control in dystrophic epidermolysis bullosa (DEB) patients
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Pediatric Dermatology